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Abstract
Glucocorticoids act in part via glucocortocoid receptor binding to hormone response elements (HREs), but their direct
target genes in vivo are still largely unknown. We developed the criterion that genomic occurrence of paired HREs at an
inter-HRE distance less than 200 bp predicts hormone responsiveness, based on synergy of multiple HREs, and HRE
information from known target genes. This criterion predicts a substantial number of novel responsive genes, when applied
to genomic regions 10 kb upstream of genes. Multiple-tissue in situ hybridization showed that mRNA expression of 6 out of
10 selected genes was induced in a tissue-specific manner in mice treated with a single dose of corticosterone, with the
spleen being the most responsive organ. Caveolin-1 was strongly responsive in several organs, and the HRE pair in its
upstream region showed increased occupancy by glucocorticoid receptor in response to corticosterone. Our approach
allowed for discovery of novel tissue specific glucocorticoid target genes, which may exemplify responses underlying the
permissive actions of glucocorticoids.
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Introduction
Glucocorticoid hormone secretion from the adrenal cortex
follows a circadian rhythm and is markedly increased in case of
physical or psychological stress, when these steroids can modulate
processes in virtually all organs in the body. Glucocorticoids can
act permissively to prepare for upcoming stressful challenges and
support ongoing stress responses, for instance via increased
gluconeogenesis and mental performance. They can also dampen
the body’s initial reaction to stress, as is the case for anti-
inflammatory effects. In addition, glucocorticoids can promote
adaptation to stress and the response to subsequent stressors, for
example by modulating memory formation. Aberrant glucocorti-
coid signalling is strongly linked to metabolic, immune, bone, and
central nervous system disease, while important pharmacological
issues include therapy resistance and side effects [1,2,3].
The actions of corticosterone (in rats and mice) and cortisol (in
most other mammals) are mediated by glucocorticoid (GR) and –
in some tissues – mineralocorticoid receptors (MR). These proteins
are members of the nuclear receptor superfamily, and they
accordingly act as transcription factors. Regulation of transcription
can occur through binding to consensus palindromic sequences in
the DNA, known as Hormone Response Elements (HREs), or
alternatively through protein-protein interactions in a manner that
is independent of direct DNA binding [4]. The latter mechanism
may be particularly relevant for the restraining effects of
glucocorticoids on activated systems, such as the suppression of
NF-kB induced activation of pro-inflammatory genes [5].
However, many important actions involve activation through
binding to HREs, as revealed by defects in dim/dim mice that are
impaired in transactivation at HREs [4,6,7].
The understanding of physiological and molecular mechanisms
of glucocorticoid action would be advanced by characterization of
a larger number of primary HRE-dependent MR and GR target
genes than are presently known. Transcriptome analysis using
SAGE and microarrays has been performed in various tissues
[8,9], recently in combination with chromatin immunoprecipita-
tion based mapping (ChIP-chip) of genomewide GR occupancy
[10]. However, there are limitations to these techniques, such as
insufficient abundance of cellular mRNA, tissue heterogeneity,
and cell type dependent responsiveness.
The availability of complete genomes has opened the possibility
of a complementary approach, namely, the prediction of
glucocorticoid responsiveness based on the presence of HREs in
the proximity of genes. We have explored this route by studying
the occurrence of HREs upstream of 23,391 multi-transcript
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transcriptional units and 22,658 single mapped transcripts (see
Material and Methods). Motivated by empirical evidence that
steroid receptors transactivate synergistically when multiple HREs
are present in a promoter, we sought to develop a criterion for
prediction GR-responsive genes based on a computational analysis
of genomewide promoter sequence data and ChIP-chip data for
promoter occupancy by GR after glucocorticoid treatment. We
concluded that paired occurrence of HREs within 10,000 base
pairs upstream of the transcription start site (TSS) at a relative
distance less than 200 bp best predicts GR responsiveness. We
validated this criterion by performing multiple-tissue in situ
hybridization on organs harvested 3 hours after corticosterone
or vehicle treatment of adrenalectomized mice. We observed that
6 out of 10 genes are indeed up regulated, in a tissue specific
manner.
Materials and Methods
Detailed description of the computational procedures and the
source code of all R and Perl scripts is available in supplementary
Documents S1 and S2.
Transcriptional Units and Upstream Regions
To define a set of non-redundant transcriptional start sites
(TSS), we used the coordinates of all full-length cDNAs and
mRNA sequences (files all_mrna.txt and refSeqAli.txt) as mapped
to the March 2005 (mm6) version of the mouse genome available
at the UCSC genome annotation project (http://hgdownload.cse.
ucsc.edu/goldenPath/mm6). Transcripts whose exons overlapped
by one or more base pairs when mapped to the genome sequence
were considered to be part of the same transcriptional unit (TU).
For purposes of motif analysis (see below), upstream promoter
regions were defined relative to TSS. To prevent double counting
of motifs, overlapping upstream regions were combined into a
single promoter region. All analyses were confined to non-repeat
DNA.
Statistics of Single HRE Consensus Matches
To analyze the spatial distribution of matches to the HRE
consensus near transcriptional start sites, we assumed a null model
in which matches occur randomly and independently throughout
the genome (Bernoulli process), at a density r equal to their actual
genomic density. Thus, the expected number of matches in a
single promoter region of length L equals r (L-LHRE+1), where
LHRE is the length of the HRE consensus. To quantify whether the
observed number of HRE consensus matches for individual
promoter regions was significantly larger than expected, P-values
were computed using the cumulative Binomial distribution
function. These P-values were used as input to the procedure of
Benjamini and Hochberg [11] to determine the total number of
promoter regions that are significantly enriched by single
consensus sites at a false discovery rate (FDR) of 5%.
Statistics of Paired HRE Matches
Given the single-HRE Bernoulli process defined above, the
occurrence of two consecutive HRE consensus matches at distance
D is again a Bernoulli process, but now at a density r2(D) given by
r2(D)~r
2 1{rð ÞD{1
Summing over D in a given inter-HRE distance range, and taking
into account the lengths of the promoter regions, we computed the
expected number of HRE pairs within a distance D.
In Situ Hybridization Experiments
The animal experiment was performed in accordance with
the European Communities Council Directive 86/609/EEC
and with approval from the animal care committee of the
Faculty of Medicine, Leiden University (UDEC number 04052).
Sixteen adult male c57bl/6 mice, 25.960.4 g (Janvier, France)
were adrenalectomized under isoflurane anaesthesia, single
housed, and fed with oats containing 400 mg corticosterone or
vehicle at t = 0 on the day of the experiment. Mice were
decapitated 3 hours after oats administration, trunk blood was
collected and organs were dissected and frozen on dry ice. Two
mice were killed at 30 minutes after treatment to determine
peak levels of hormone. Plasma corticosterone was determined
by radio immuno assay (ICN Biomedicals, Costa Mesa, CA).
Tissues were cut at 16 mm in a cryostat and collected on poly-L-
lysine coated slides. In situ hybridisation with 33P end-labelled
45-mer oligodesoxynucleotide probes targeting the first exon of
the mRNAs was performed as described [12] probe containing 7
mismatches relative to the anti-sense probes were used as
controls. Probe sequences can be found in Table S1 of the
additional information. Three exposures (1, 3 and 10 days) of
autoradiograms were made to keep the signal in the linear range
for all organs, irrespective of absolute level of expression.
Autoradiograms were quantified using ImageJ software. Differ-
ences between groups were analyzed using Student’s t-test. The
null hypothesis was rejected at P,0.01.
Chromatin Immuneprecipitation
A549 human lung carcinoma cell line were grown and
maintained in DMEM containing 4.5 g/l glucose, supplemented
with 10% Foetal Bovine Serum, penicillin (20 U/mL) and
streptomycin (20 ug/mL; all Invitrogen). A day prior treatment,
106106 cells were seeded on 150 mm dishes. The following day,
the cells were treated either with ethanol (vehicle) or 1027M
dexamethasone (DEX) for 90 min. and cross-linked to stop
reactions. Chromatin immumeprecipitation was performed as
described [21]. Fixed chromatin was sheared, yielding fragments
of 100–500 bp (20 pulses of 30 seconds; Bioruptor, Diagenode).
Immunoprecipitation was performed with either 6mg of GR-
specific H300 or normal rabbit IgG (Santa Cruz Biotechnology)
overnight at 4uC. After DNA recovery (Nucleospin, Macherey-
Nagel), RT-qPCR was performed to study enrichment of the
human Cav-1 GRE-1 (GAAACAGAATGTTCT ) (LightCycler
FastStart DNA Master PLUS SYBR Green I, Roche), according
to manufacturer’s instructions. Primers were designed immediately
adjacent to the glucocorticoid response element: TGGCTC-
TTTGGCACTGAGTA (forward), and TGCAGTTTGAAA-
TCCCAACA (reverse). Myoglobulin was used a negative control
for GR chromatin occupancy: CCTCACATGGGCAGCTATTT
(myoglobin forward); GCTTGTGCAAGTCCAGACAG (myo-
globulin reverse). Recovery of DNA was calculated as percentage
of input material of the immunoprecipitation.
Results
HRE Consensus
Our aim is to predict glucocorticoid-regulated genes based on
the spatial distribution of hormone response elements (HREs) in
their upstream region. Definition of the HRE consensus
sequence is therefore the first step in our analysis. While the
canonical HRE is defined as the palindromic sequence
AGAACANNNTGTTCT, many variations are possible, par-
ticularly in the 39 half site, both in naturally occurring sites
[10,13], and in parametrically tested variable HREs [14]. Based
HRE Predict GR-Target Genes
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on these studies, we settled on NGNWCDNNNWGTYCT as a
low-stringency definition of the HRE and matched this
sequence to both strands to find HREs (coding is according to
the IUPAC convention: W= [AT]; S = [CG]; D= [AGT];
Y = [CT]). This sequence is close to the major variants from
the TRANSFAC M00205 GRE matrix.
Single HREs Are Uniformly Distributed Relative to the
Transcription Start Site
Many transcription factors are known to bind preferentially in
the vicinity of transcription start sites, including E2F, which
binds to TTSGCGC [15]. As a positive control, we determined
the distribution of matches to this E2F consensus relative to the
TSS (Fig. 1A, red symbols). Indeed, the E2F site occurs more
often close to the TSS than at larger distances. This result also
indicates that our set of coordinates represents bona fide
transcription start sites. Matches to the HRE consensus, by
contrast, do not show any enrichment near the TSS (Figure 1A,
blue symbols). Concordantly, the observed/expected ratio of
consensus matches increases with increasing proximity to the
TSS for the E2F, but not for the HRE consensus (Figure 1B). In
addition, when enrichment of upstream consensus matches for
individual genes is used to define putative cis-regulatory targets
Figure 1. Spatial distribution of matches to the E2F (red) and
GR (blue) consensus relative to the transcription start site
(TSS). (A) The mean density of response elements over all regions
upstream of the TSS for different sizes of the upstream region. The
computation of the density was confined to non-repeat DNA. (B) Ratio
of observed and expected number of matches versus maximum
distance to the TSS. (C) Number of putative target genes at a false
discovery rate of 5%, based on enrichment of consensus matches in
upstream region, versus maximum distance to the TSS.
doi:10.1371/journal.pone.0008839.g001
Figure 2. Establishing a criterion for predicting GR target genes
based on genomewide analysis of spatial HRE clustering and
its association with ChIP-chip data for GR promoter occupancy.
(A) Testing for spatial clustering of HREs. Shown is the ratio of observed
and expected genomewide density of pairs of HRE matches versus
inter-HRE distance. (B) Testing whether paired HREs are predictive of GR
binding to upstream regions. Shown is the statistical significance of a
non-parametric test for increased occupancy by GR of the upstream
regions of putative GR targets, for various combinations of maximum
distance upstream of the TSS and maximum inter-HRE distance
(indicated by different colours).
doi:10.1371/journal.pone.0008839.g002
HRE Predict GR-Target Genes
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at a false discovery rate of 5% (see Methods), a significant
number of genes is found only for E2F (Figure 1C). We conclude
that the spatial distribution of single HREs cannot be used to
define a criterion for selecting genes responsive to GR,
consistent with recent data showing that functional steroid
receptor binding occurs over large distances up- and down-
stream of transcription start sites [16].
Pairs of HRE Matches within 200bp Are Overrepresented
Genomewide
The absence of any enrichment of single HREs near the TSS
motivated us to investigate the spatial clustering of HREs. It is
known that paired occurrence of HREs at relatively close
proximity can synergistically stimulate transcription [17,18], and
therefore it may serve as a criterion to predict GR-responsive
target genes. Relevant variables in this case are the inter-HRE
distance and the distance to the TSS. Assuming a random
genomewide spatial distribution of single HREs, the density of
pairs of HREs at a given inter-HRE distance can be easily
computed (see Materials and Methods). Comparison of the
observed and expected genomewide density of HRE pairs shows
enrichment at inter-HRE distances shorter than 200 bp
(Figure 2A). We conclude from this that there exists evolutionary
pressure to maintain such proximal HRE pairs.
Paired HRE Occurrence Correlates with Measured GR
Occupancy
Phuc Le et al. [19] used genomewide chromatin-immunopre-
cipitation (‘‘ChIP-chip’’) to measure occupancy by GR in
dexamethasone-treated liver samples in the upstream regions of
3291 RefSeq genes important for liver function. We split this set of
genes into two parts, putative targets and non-targets, based on
whether or not pairs of HRE matches within a given maximum
HRE-distance occurred within a given maximum upstream
distance from the TSS. We tested whether the observed ChIP
enrichment ratios were significantly larger for putative GR targets
Figure 3. GILZ mRNA expression and its up-regulation three hours after corticosterone treatment of adrenalectomized mice. The
average grey value quantified using Image J in the lung (A), liver (B), kidney (C), spleen (D), and brain (E). Bars represent mean6 standard error of the
mean of 7 mice/group. Asterisk indicates significant different from control animals.
doi:10.1371/journal.pone.0008839.g003
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than for non-targets, using the non-parametric Mann-Whitney
test. Consistent with the genomewide sequence analysis result
presented in Figure 2A, we found a maximum inter-HRE distance
of 200 bp to be optimal for maximum TSS distances of 10kb and
higher (Figure 2B).
A Genome-Wide Scan Predicts 2746 Putative GR Targets
We settled on the criterion that each documented mRNA
transcript with an occurrence of two HRE consensus matches
within 200 bp from each other and at most 10 kb upstream of its
TSS is a putative target of the GR. A genomewide scan identified
2,746 transcripts, corresponding to 553 TUs in the mouse
genome. The genomic locations of the HRE pairs corresponding
to these putative GR targets are available in GFF and Excel
format as Supplementary Information (tables S2 and S3). They
can be visualized in the context of the genome annotation by
uploading the GFF file to the UCSC genome browser ([http://
genome.ucsc.edu).
Validation
To evaluate the predictive value of paired HREs in genomic
regions upstream of transcription start sites, we tested 10 genes
from the list of putative GR targets for their responsiveness to
glucocorticoids in vivo. The genes were selected for heterogeneity of
HRE characteristics, such as distance from TSS, sequence
variability, and total number of HREs in the cluster. Apart from
the number of GREs (which was 2 for the majority of identified
clusters) these characteristics showed no particular pattern. We
administered corticosterone to adrenalectomized mice in a dose
sufficient to occupy both mineralo- and glucocorticoid receptors
(peak levels of plasma corticosterone 30 minutes after administra-
tion were 2868 mg/dl). Based on the prediction of primary
responses we decapitated animals after 3 hours. Since there can be
a considerable degree of cell-specificity in the transcriptional
response to glucocorticoids, we harvested multiple organs and
evaluated expression and regulation of the mRNAs using multiple
tissue in situ hybridisation.
Table 2. Characteristics of the HREs in the validated (upper six) and false positive (bottom 4) predicted GR targets.
Name/Gene symbol/Direct target GRE-sequence Distance to TSS(kb)
Inter-GRE
distance(bp)
Zinc finger protein 513/Zfp513/NM_175311 AGGACTGGTAGTTCT
TGCTCATAGTGTCCT
0.6 156
Adult male cortex/530002H17/AK046725 GGCTCGGGAAGTTCT
AGGTCATCTTGTCCT
5.2 111
caveolin-1,caveolae protein/cav/AK010839/ AGTTCTGAATGTTCT
GGAACAGAATGTTCT
2.9 116
0 day neonate thymus cDNA/A430010E21Rik/AK039823
(adjacent to Rfx3)
TGCACTCGCTGTCCT (6x) 6.5 5651
Paraneoplastic antigen MA2/Pnma2/NM_175498 AGCTCTGGCTGTCCT
GGAACTCAGAGTTCT
2.1 44
RAN binding protein 10/Ranbp10/NM_145824/ TGGACTAGTAGTCCT
GGGACACTCTGTTCT
AGGACAACCAGAGCT
AGATCTCTGAGTTCT
4.1 158/105/44
LPS-induced TN factor/Litaf/AK150476 GGCACTTCATGTTCT
GGCACTTCATGTTCT
AGGTCAGGCTGTCCT
6.6 41/120
acetyl-Coenzyme A synthetase 2/Acss1/AK004042 AGTTCATGAAGTTCT
AGTTCATGAAGTTCT
AGTTCATGAAGTTCT
3.5 16/16
WAS protein family member 2/Wasf2/AK198823 AGCTCACTCTGTCCT
AGCTCTGGCAGTCCT
6.8 114
microsomal glutathione S-transferase 1/Mgst1/NM_019946 AGCTCTTTAAGTCCT
TGCACTCAGTGTTCT
1.2 61
doi:10.1371/journal.pone.0008839.t002
Table 1. Results on multi-tissue in situ hybridization
experiments.
Organ
Number of genes
detected
Number of genes
regulated
Spleen 10 6
Thymus 7 2
Lung 2 1
Brain 6 1
Kidney 3 1
Heart 3 0
Liver 5 0
Colon 5 0
Ileum 5 0
Testis 2 0
Muscle 2 0
The number of transcripts expressed before corticosterone treatment, and the
number of transcripts differential expressed 3 hours after that treatment, in
different mouse tissues.
doi:10.1371/journal.pone.0008839.t001
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As a positive control we included measurement of GILZ mRNA
[20] which was up-regulated in multiple tissues, including lung
(Figure 3A), liver (Figure 3B), kidney (Figure 3C), spleen
(Figure 3D) and brain (Figure 3E) [21]. All 10 probes against
mRNAs containing compound HREs in their flanking region gave
a specific signal in at least one tissue; the mismatch control probes
gave no signal (not shown). Expression levels of six out of ten
mRNA were increased in at least one tissue, 3 hours after
corticosterone treatment (Table 1, Table 2, and Figure 4A). Most
responsive mRNAs were found in the spleen: 6 out of 10 spleen-
expressed mRNAs were up-regulated by 40 to 70%. Four
transcripts showed no induction (Figure 4B). The high number
of reactive mRNAs in spleen may in part reflect trafficking of
lymphocytes upon exposure to corticosterone [2]. However, cresyl
violet staining of the sections did not reveal differences is cell
density in the spleen.
For 3 out of the 10 mRNAs we found significant up-regulation
in other tissues that were evaluated, i.e. thymus, lung, kidney and
brain (Figure 4A). The highest and most widespread induction was
observed for caveolin-1 mRNA, which in lung, kidney, and spleen
was up-regulated by 15–50%, while not in heart. (Figure 4C and
Figure 5).
As an additional validation we performed chromatin immune
precipitation on the GRE upstream of the caveolin-1 gene in a
human lung carcinoma cell line (Figures 6, 7). Dexamethasone
treatment led to a modest (,2-fold) but significant enrichment of
the GRE-associated DNA after precipitation with the GR
antibody, but not with IgG. For the negative control DNA, the
myoglobin locus, no enrichment was observed.
Discussion
Through computational analysis of the spatial distribution of the
GR consensus binding motif in upstream promoter regions, and its
relationship with GR occupancy as measured using ChIP-chip, we
have developed a simple criterion that allows for prediction of in
vivo glucocorticoid responsiveness based on the 10kb sequence
upstream of the transcriptional start site of each mRNA transcript
annotated in the mouse genome. Testing 10 genes chosen from the
list of putative targets, we identified six novel corticosterone-
responsive genes. Most regulated mRNAs were found in the
spleen. Caveolin-1 and two other genes showed regulation in other
tissues.
A requirement for paired occurrences of the HRE within
,200bp was part of our final criterion for predicting target genes.
We found that larger or smaller inter-HRE distance cut-offs gave
worse correspondence with genome-wide ChIP-chip measure-
ments of GR occupancy. The length scale of ,200bp is similar to
that of nucleosomal DNA, which is ,147bp. It is tempting to
speculate that the simultaneous binding of two GR molecules to
distinct but proximal HREs helps displace nucleosomes that block
access to the DNA. Such nucleosome-mediated cooperativity has
been observed in other contexts [22,23], and it is known that cis-
regulatory elements occurring within clusters of transcription
factor binding sites are more likely to be functional in vivo [24]. For
73 genes, we found more than one HRE pair in their upstream
region.
The strongest responsive gene we identified is caveolin-1. The
gene was up regulated in lung, kidney, and spleen; in most other
tissues expression was too low to be quantified in a reliable way.
The HRE matches that led to identification of caveolin-1 as a GR
target occur at position 21526 bp upstream of the cav-1
transcription start site. Consistent with the notion that functional
GR-binding sequences are evolutionary conserved [16], we found
that the GREs upstream of caveolin-1 in mouse are conserved in rat
(one mismatch in each HRE) and, to a lesser degree, in human
(Figure 6). The surrounding sequences of the two GREs were also
conserved. ChIP data on A549 cells lend support to the
functionality of this GRE in multiple species. Unfortunately, the
ChIP methodology may not have sufficient resolution to
distinguish between the two GREs, given the fragment length of
up to 500 bp. Earlier studies have implicated the androgen
receptor (AR) in human prostate cancer cells [25] and the
progesterone receptor (PR) in breast cancer cells [26] as
stimulators of caveolin-1 expression. The AR and PR can both
recognize the low-stringency HRE sequence we used when tested
in isolation [14], and the conserved HREs may mediate the effects
of PR and AR in vivo.
Caveolin-1 has recently received substantial attention [27].
Caveolines (cav-1, cav-2, cav-3) are major constituents of
caveolae, which are small invaginations of the plasma mem-
brane that function as vesicular transporters [28]. Among them
Figure 4. In situ hybridization results for predicted GR targets, 3 hours after corticosterone. Ten genes containing compound HREs in
their 10 kb upstream region that were tested. (A) Up-regulation of 5 mRNAs in spleen(s), thymus (th) and brain(b). (B) The hybridization signal in
spleen of 4 genes did not show detectable up-regulation in any of the measured organs. (C) Caveolin-1 mRNA was strongly up regulated in lung (lu),
kidney (k), and spleen (s), but not in heart(h).
doi:10.1371/journal.pone.0008839.g004
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caveolin-1 was the first to be discovered and has been
characterized most extensively [29,30]. Caveolin-1 forms a major
component of caveolae, which are involved in sub-cellular
transport, cholesterol homeostasis, as well as signal transduction.
Caveolin-1 may play a role in non-genomic steroid receptor
mediated effects [31,32] and has been implicated in several
types of cancer, metabolic, and cardiovascular disease, and via
its link with cholesterol transport in Alzheimer’s disease [33].
Interestingly, caveolin-1 knockout mice suggest a permissive
function of the protein: while its absence leads to disappearance
of caveolae in many organs, the mice are viable and fertile.
However, these animals are much more susceptible to numerous
challenges, which may lead to development of diabetes and
cancer. Caveolin-1 seems to be a good example of a gene that is
regulated by corticosterone in absence of challenge and involved
in permissive hormone effects.
With respect to the other hits from our genomic search, the
simple criterion we applied necessarily must have yielded
numerous false negative results. A number of known regulated
genes (e.g. PNMT, GILZ) were simply lacking either because
functional HREs occur singly (or as pairs at an inter-HRE distance
.200 bp), do not match our consensus, are located in intronic
regions [16,34,35,36], are further upstream than 10 kb [16], or
occur in repeat DNA. Also, only the most upstream transcription
start sites of genes were considered. The frequency of occurrence
of the low-stringency HRE that we used is on the order of
1025 bp21, and selection of promoters with single elements will
likely result in a high false-positive rate. Yet, the validity of our
HRE definition is supported by the fact that the nucleotide
sequence of the HREs occurrences for our responsive genes covers
almost the entire range of our low-stringency consensus. The
predictive value of the compound (paired) HREs may increase by
the use of weight matrices [37,38] selection for cross-species
conservation (as present in the cav-1 gene), and taking into account
the presence of non-HRE binding sites of co-factors [19,39].
Some of the changes in transcript levels that we observed may
be secondary effects, i.e. changes in gene expression that are
induced by the product of a primary corticosterone-responsive
gene. However, we interpret our set of predicted GR targets as
strongly enriched for primary responsive genes, given the selection
criterion, the relatively short time after treatment, and the fact that
the mRNAs were always up regulated, as would be expected from
the compound HRE mediated action. Lastly, the HREs we
identified do not necessarily mediate the corticosterone-induced
transactivation. Some strongly steroid responsive genes such as
PNMT and GILZ contain multiple HRE-like sequences, not all of
which are necessary for induction by hormones [10,13]. Our
selection criterion may simply select for such HRE-rich genomic
stretches. Additional evidence for involvement of particular HREs
could come from studies in cell lines using chromatin immuno-
precipitation of GR/MR, and mutation of candidate HREs in
reporter studies.
Effects of glucocorticoids depend heavily on the physiological
state of the animal. For example, mRNA induction in liver, a
classical target tissue, is very weak in mice that are well fed,
compared to mice that are starved [19]. This may explain why we
did not observe any effect of corticosterone on the putative target
genes in the liver. Our results indicate that the spleen is highly
responsive to acutely elevated corticosteroid levels. While we did
not determine the exact cell type in which regulation occurred, it is
Figure 6. Alignment of caveolin-1 putative GREs in human, rat
and mouse genome. Mouse caveolin-1GRE-(1) is located 1526 bp
before TSS; only one nucleotide is different in the rat and human
genome. GRE(2) is located at position 21643. The left half-site of
second GRE in mouse is conserved in the rat, but the sequence is not
well conserved in human.
doi:10.1371/journal.pone.0008839.g006
Figure 5. Caveolin-1 mRNA expression of vehicle versus
corticosterone treated animals. The average grey value quantified
using image J analysis in lung (A), kidney (B) and spleen(C).Bars
represent mean 6 standard error of the mean of 7 mice/group. Asterisk
indicates a significant different value from that of control animals.
doi:10.1371/journal.pone.0008839.g005
HRE Predict GR-Target Genes
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tempting to link these findings to the immune system, which has
long been recognized as a target of corticosteroids in delayed anti-
inflammatory effects [40]. However, acute exposure to glucocor-
ticoids can have immune-enhancing effects, which have been
interpreted as permissive [2,41]. Corticosterone treatment has
been shown to allow higher production of anti-CD3 induced IL-4
production in spleen lymfocytes [42] and can acutely enhance
splenic T cell proliferation [43]. The products of up-regulated
mRNAs as identified under the present conditions may mediate
such permissive effects. On the other hand, immune-suppressive
effects like apoptosis can also depend on induction of target genes
via HREs [4].
Our decision to look for compound HREs was based on the
expectation of a large response due to transcriptional synergy. The
set of currently identified targets may represent examples for some
promoter (paired HRE) dependent phenomena that have been
described in experimental settings, but do not have clear
physiological interpretation, such as SUMO-ylation-dependent
synergistic activation [44] differential coregulator efficiency
[45,46], and receptors with mutated dimerization domains that
retain transactivation potential at compound HREs [4,13,47].
In conclusion, we have demonstrated successful prediction of
glucocorticoid-regulated genes in vivo from a genome wide screen
for compound HREs in regions upstream of transcription units.
Our findings suggest prominent and acute effects of corticosterone
on the spleen, and reveal caveolin-1 to be strongly regulated by
corticosterone in several tissues. While future searches will need to
incorporate additional criteria, including sequence conservation,
our results suggest a new approach to understand stress regulated
disease in the context of the whole animal, rather than single cell
lines [48].
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